{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-045573","form_type":"8-K","ticker":"CTXR","cik":"0001506251","company_name":"Citius Pharmaceuticals, Inc.","filed_at":"2024-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.724328+00:00","generated_at":"2026-06-01T10:43:54.776561+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Citius Pharma: Mino-Lok Phase 3 trial meets primary endpoint (p=0.0006) in CLABSI/CRBSI","bullets":["Primary endpoint: time to catheter failure significantly delayed for Mino-Lok vs control (p=0.0006); hazard ratio 0.53.","Median time-to-failure for control arm: 33 days; Mino-Lok arm median not reached (NE; CI 50 days-NE).","Secondary endpoint overall success: 57.1% Mino-Lok vs 37.7% control (p=0.0025).","No drug-related serious adverse events reported; safety profile supports well-tolerated designation.","Company plans to engage with FDA to determine next regulatory steps for Mino-Lok."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-045573","json":"https://secwatch.observer/filing/0001213900-24-045573.json","markdown":"https://secwatch.observer/filing/0001213900-24-045573.md","text":"https://secwatch.observer/filing/0001213900-24-045573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024045573/0001213900-24-045573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024045573/ea0206620-8k_citius.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T10:43:54.776561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}